240 related articles for article (PubMed ID: 19339206)
1. In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine.
Nadtochiy SM; Burwell LS; Ingraham CA; Spencer CM; Friedman AE; Pinkert CA; Brookes PS
J Mol Cell Cardiol; 2009 Jun; 46(6):960-8. PubMed ID: 19339206
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury.
Nadtochiy SM; Burwell LS; Brookes PS
J Mol Cell Cardiol; 2007 Apr; 42(4):812-25. PubMed ID: 17350035
[TBL] [Abstract][Full Text] [Related]
3. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning.
Dost T; Cohen MV; Downey JM
Basic Res Cardiol; 2008 Jul; 103(4):378-84. PubMed ID: 18347834
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture.
Kohr MJ; Sun J; Aponte A; Wang G; Gucek M; Murphy E; Steenbergen C
Circ Res; 2011 Feb; 108(4):418-26. PubMed ID: 21193739
[TBL] [Abstract][Full Text] [Related]
5. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-(2-mercaptopropionyl)-glycine on mitochondrial function in ischemic-reperfused heart.
Tanonaka K; Iwai T; Motegi K; Takeo S
Cardiovasc Res; 2003 Feb; 57(2):416-25. PubMed ID: 12566114
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
[TBL] [Abstract][Full Text] [Related]
8. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
[TBL] [Abstract][Full Text] [Related]
9. Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles.
Feige K; Raupach A; Torregroza C; Muehlenbernd J; Stroethoff M; Bunte S; Hollmann MW; Huhn R
PLoS One; 2020; 15(12):e0243220. PubMed ID: 33270768
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.
Chouchani ET; Methner C; Nadtochiy SM; Logan A; Pell VR; Ding S; James AM; Cochemé HM; Reinhold J; Lilley KS; Partridge L; Fearnley IM; Robinson AJ; Hartley RC; Smith RA; Krieg T; Brookes PS; Murphy MP
Nat Med; 2013 Jun; 19(6):753-9. PubMed ID: 23708290
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts.
Shao Q; Casin KM; Mackowski N; Murphy E; Steenbergen C; Kohr MJ
PLoS One; 2017; 12(5):e0177315. PubMed ID: 28493997
[TBL] [Abstract][Full Text] [Related]
13. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway.
Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT
J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
Nuñez RE; Javadov S; Escobales N
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the mitochondrial calcium uniporter in cardioprotection by ischemic preconditioning.
Zhang SZ; Gao Q; Cao CM; Bruce IC; Xia Q
Life Sci; 2006 Jan; 78(7):738-45. PubMed ID: 16150463
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts.
Methner C; Chouchani ET; Buonincontri G; Pell VR; Sawiak SJ; Murphy MP; Krieg T
Eur J Heart Fail; 2014 Jul; 16(7):712-7. PubMed ID: 24891297
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-A mimicked the ischemic pre- and postconditioning-mediated cardioprotection in hypertensive rats: Role of PKCε.
González Arbeláez LF; Ciocci Pardo A; Fantinelli JC; Mosca SM
Exp Mol Pathol; 2016 Apr; 100(2):266-75. PubMed ID: 26844384
[TBL] [Abstract][Full Text] [Related]
18. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
19. Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation.
Leung CH; Wang L; Nielsen JM; Tropak MB; Fu YY; Kato H; Callahan J; Redington AN; Caldarone CA
Cardiovasc Drugs Ther; 2014 Feb; 28(1):7-17. PubMed ID: 24018748
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
